Viewing Study NCT04165967


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-01-07 @ 8:08 AM
Study NCT ID: NCT04165967
Status: COMPLETED
Last Update Posted: 2024-04-10
First Post: 2019-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma
Sponsor: University Hospital, Basel, Switzerland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module